POMDOCTOR Initiates U.S. Market Entry Preparations, Advancing Global Growth Strategy

POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ:POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions, today announced the formal initiation of its U.S. market entry preparations, marking a decisive advancement in its global growth strategy.

As part of the initiative, Pomdoctor has recently commenced recruitment for core U.S.-based leadership and operational roles, completed an initial assessment of the U.S. healthcare market, and begun structuring a dedicated local compliance and regulatory framework. Concurrently, the Company is advancing product localization efforts and engaging in exploratory discussions with potential U.S. partners across the healthcare sector.